OMDA — OMADA HEALTH INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About OMADA HEALTH INC (OMDA)
OMADA HEALTH INC (OMDA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $36M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in OMDA
How many top investors track OMDA
A small number of top investors own this.
OMDA Ownership Composition
How OMADA HEALTH INC is held across tracked investor types, based on reported 13F positions.
- Other66.8%
- Hedge Funds33.2%
Tracked investors reporting OMDA
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.1MValue$13.9M% Portfolio0.01%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares343.2KValue$4.3M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares906.2KValue$11.4M% Portfolio0.01%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares378.4KValue$4.8M% Portfolio0.01%
Recent activity
- New$4.3MMay 15, 2026
Frequently asked questions
- How many institutional investors hold OMDA?
- 4 tracked institutional investors disclosed a position in OMDA (OMADA HEALTH INC) in their most recent 13F filing.
- Who is the largest institutional holder of OMDA?
- Izzy Englander, Millennium Management, holds the largest disclosed position in OMDA, valued at $36M.
- Did institutional ownership of OMDA increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited OMDA.
- Where does this OMDA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.